The World Bio Summit 2023 will gather experts to address a wide range of topics on the future of the bio industry, from pandemic preparedness to applications of artificial intelligence, organizers said Sunday. “In the presence of global leaders from governments, the scientific community, the private sector, and international organizations related to vaccine and biologics, the two-day Summit will explore what we.
(2)
Novel approach for minimizing investment risks and stretching limited budgets has 375 innovations targeting infectious diseases under development
NEW YORK, Jan. 28, 2021 /PRNewswire/ The public-private initiatives that contributed to COVID-19 vaccine and drug development have showcased a model for accelerating biomedical innovation. However, the effectiveness of public-private partnerships in fighting global health threats had emerged long before this pandemic hit. Over the last decade, such alliances have produced a wide assortment of life-saving technologies targeting diseases that afflict billions in low-income countries, according to a new report from a group of 12 product development partnerships (PDPs) that assesses their impact and future potential.
Last modified on Wed 23 Dec 2020 14.02 EST
Experts fear a push to cut the UK’s aid budget will slash spending on global health research, handicapping international public-private programmes that have helped combat the world’s deadliest diseases over the last decade.
In a letter addressed to the foreign secretary, Dominic Raab, last week, prominent parliamentarians sought reassurance that the planned cuts would not lead to “dramatic reductions” in investment for devastating diseases such as tuberculosis, malaria, Aids and a clutch of neglected tropical diseases.
The letter’s signatories include the former health secretary Jeremy Hunt, the chair of the science and technology select committee, Greg Clark, the chair of the international development committee, Sarah Champion, and the Tory peer Nick Herbert, the letter’s lead signatory.